We are aiming to revolutionise clinical trials in Parkinson’s disease, by developing a multi-arm, multi-stage platform to accelerate our search for a cure. Currently, there is a gap between each phase of clinical trial, which adds significant delays. Each time a new trial starts, its infrastructure has to be rebuilt from scratch. With Parkinson’s being the fastest growing neurological condition in the world, we need a more efficient way to find answers.
The EJS ACT-PD initiative is funded by The Edmond J Safra Foundation. The initiative has successfully led to the development of the EJS ACT-PD platform trial, which is funded by NIHR, Cure Parkinson’s, Parkinson’s UK, Gatsby Foundation, John Black Charitable Foundation, Neuro VC and Bayshore. The trial is co-led by UCL and Newcastle University, in collaboration with the MRC Clinical Trials Unit at UCL.